hip implant

iStock_000012455703Small
Recently I wrote about how Johnson & Johnson inappropriately marketed Risperdal to treat agitation, confusion and other symptoms in older patients with dementia. As if that's not enough, the company's now tentatively agreeing to a $4 billion - yes, that's  billion - settlement with thousands of patients for whom a company-made hip implant failed.
Search AARP Blogs